Julie Henderson (Acting Head of Clinical Services) discusses the Clinical Audit Service:
- Clinical Leadership and Engagement
- Inclusive Approach
- Audit Measurement
This presentation includes two case studies:
1) National Diabetes Audit
2) National Lung Cancer Audit
Julie Henderson (Acting Head of Clinical Services) discusses the Clinical Audit Service:
- Clinical Leadership and Engagement
- Inclusive Approach
- Audit Measurement
This presentation includes two case studies:
1) National Diabetes Audit
2) National Lung Cancer Audit
This workshop will look at patient care pathways and demonstrate how simulation can combine process flow across; services, clinical best practice and the progression of patients through disease states, to test the impact of improvement initiatives on patient care, outcomes, costs and resource utilization.
Using examples from recent projects on simulating care pathways within HIV services, and simulating future service needs for dementia care, we show the results of combining disease progression with service utilization.
In the workshop, we’ll consider what the ideal pathway model would look like and invite you to work with us to build a pathway using our latest technology.
CAHPO 2016. Workshop 1: Nathan HumphriesNHS England
Chief Allied Health Professions Officer’s Conference 2016
Workshop 1: Urgent and emergency care – Chair Helen Marriott
Physiotherapist in A&E. Nathan Humphries, Emergency Department Advanced Clinical Practitioner and Physiotherapist and Greg Markham, Advanced Clinical Practitioner Paramedic Heart of England NHS Foundation Trust.
Developing an effective local quality improvement programmeCarl Walker
I gave this presentation at Clinical Audit for Improvement conference in October 2016 on behalf of National Quality Improvement & Clinical Audit Network (@nqican)
Presentation by Carmel O'Brien, Chief Nurse and Quality Officer at East Leicestershire and Rutland Clinical Commissioning Group to the Patient and Public Engagement Group on 15th July 2015
The Clinical Trials Portal supports improved cancer clinical trial activity data capture, monitoring and reporting across NSW. Find out more about cancer clinical trials in NSW.
Presentation from NHS Improvement endoscopy workshop held at Ambassadors Hotel, London on 29 January 2013
http://www.improvement.nhs.uk/diagnostics/EndoscopyImprovement/Events.aspx
Improving endoscopy admin systems - a trial of direct booking
Wendy Mitchell
James Paget University Hospitals NHS Foundation Trust
This workshop will look at patient care pathways and demonstrate how simulation can combine process flow across; services, clinical best practice and the progression of patients through disease states, to test the impact of improvement initiatives on patient care, outcomes, costs and resource utilization.
Using examples from recent projects on simulating care pathways within HIV services, and simulating future service needs for dementia care, we show the results of combining disease progression with service utilization.
In the workshop, we’ll consider what the ideal pathway model would look like and invite you to work with us to build a pathway using our latest technology.
CAHPO 2016. Workshop 1: Nathan HumphriesNHS England
Chief Allied Health Professions Officer’s Conference 2016
Workshop 1: Urgent and emergency care – Chair Helen Marriott
Physiotherapist in A&E. Nathan Humphries, Emergency Department Advanced Clinical Practitioner and Physiotherapist and Greg Markham, Advanced Clinical Practitioner Paramedic Heart of England NHS Foundation Trust.
Developing an effective local quality improvement programmeCarl Walker
I gave this presentation at Clinical Audit for Improvement conference in October 2016 on behalf of National Quality Improvement & Clinical Audit Network (@nqican)
Presentation by Carmel O'Brien, Chief Nurse and Quality Officer at East Leicestershire and Rutland Clinical Commissioning Group to the Patient and Public Engagement Group on 15th July 2015
The Clinical Trials Portal supports improved cancer clinical trial activity data capture, monitoring and reporting across NSW. Find out more about cancer clinical trials in NSW.
Presentation from NHS Improvement endoscopy workshop held at Ambassadors Hotel, London on 29 January 2013
http://www.improvement.nhs.uk/diagnostics/EndoscopyImprovement/Events.aspx
Improving endoscopy admin systems - a trial of direct booking
Wendy Mitchell
James Paget University Hospitals NHS Foundation Trust
In this webinar, we review the Clinical Nurse Specialist Perioperative Certification Exam (CNS-CP) and who it is for, how to prepare for it, and how it will elevate the care given to patients. The purpose of the CNS-CP Exam is to provide recognition for those CNSs serving in an advanced practice perioperative specialty. Please watch the recorded version on YouTube at https://youtu.be/MtjcBYnFu2o
In this webinar, we review the Clinical Nurse Specialist Perioperative Certification Exam (CNS-CP) and who it is for, how to prepare for it, and how it will elevate the care given to patients. The purpose of the CNS-CP Exam is to provide recognition for those CNSs serving in an advanced practice perioperative specialty. Please watch the recorded version on YouTube at https://youtu.be/MtjcBYnFu2o
Call-takers/dispatchers’ preparation and performance pre-determines the quality and ultimate effectiveness of the potentially lifesaving emergency services, therefore training is crucial. But all of the training in the world is useless if the call-taker/dispatcher isn’t being continuously monitored and reinforced for proper procedures.
Chair: Marko Nieminen, Director, Emergency Response Centre Administration, Finland
Accreditation for Postgraduate Residency Programs (Nurse Practitioner and Cli...CHC Connecticut
This webinar explored the accreditation process for postgraduate residency programs within health centers. Avenues for accreditation were discussed specifically for postgraduate nurse practitioner and psychology residency programs. Speakers discussed their experiences in the accreditation process.
The webinar was presented April 27, 2016 3:00 PM Eastern Time as part of the CHC Clinical Workforce Development National Cooperative Agreement.
Understanding and implementing quality management system in medical laboratoriesPathKind Labs
QMS is essential to run a good laboratory, but the various requirements pose a big challenge. Once you understand the reason for these requirements compliance may be easier.
This presentation offers guidance to those hospitals that are rolling out a new pharmacy program as well best practices for maintaining and continuously improving current programs. Take a look and find out why annual program reviews are highly recommended.
Digital screening information event 2 October 2019PHEScreening
Slides from the event for antenatal screening co-ordinators in Birmingham on 2 October 2019 to discuss the plans for moving to digital screening information.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
AAA London Network Event 27 Nov 2015 Patrick Rankin education and training update abridged presentation
1. Public Health England is responsible for the NHS Screening Programmes
Abdominal Aortic Aneurysm
Education and training update
LondonAAAnetworking day
27 November 2015
Patrick Rankin, National training and education manager
2. Introduction
• DES and NAAASP National teams combined in 2012
• Now includes cancer programmes too
• Bowel, breast, cervical
• New screening division within PHE
• Quality assurance, ANNB, cancer, non cancer and comms/education
• Education and training manager
• overarching responsibility for the initial and ongoing training of all staff
within the DES and AAA screening programmes
• includes continuing professional development
• technician re-accreditation/DES TAT
• e-learning
• development of new qualification main work stream this year
• CPD framework 2016-17
• busy, busy, busy!
2 London AAA update
4. Staff and responsibilities in NAAASP
• clinical director
• programme co-ordinator
• screening technicians
• clinical skills trainer/QA lead
• programme administrator
• nurse specialist
4 London AAA update
5. Clinical Director (0.2 WTE)
• Consultant vascular surgeon
• strategic lead for the programme
• ultimately responsibility for programme
• QA, IQA, funding, data submission
• advise on clinical matters and patients in pathway
• support co-ordinator and wider team (approachable and
involved)
• act on reports and data provided by NAAASP
• ensure diagnostic and treatment services meet demand of
programme
• ensure tracking of patients referred for treatment and final
outcomes
5 London AAA update
6. Programme co-ordinator (1.0 wte)
• Responsible to the clinical director
• Day to day operational management of the programme
• Management, recruitment, overseeing training,
development, tracking referrals, stakeholder
communication, ensuring screening is fit for patch,
protocol adherence, failsafe monitoring, quality
assurance, equipment QA and procurement,
performance management etc etc.
• Needs to know everything that’s going on; ‘NAAASP
crystal ball’
• No specific requirement for training/qualification
• Understanding of screening is helpful
6 London AAA update
7. Programme administrator (1.0 wte)
• Absolutely key to a well ran service
• Provides primary contact with the public
• Letters and booking clinics
• Audits
• Required to give correct and factual information to
members of the public
• No specific qualification required but admin experience is
essential
• Quite often trained to be technicians!
7 London AAA update
8. Screening technicians
• Qualifications required;
• Good standard of education
• Determined locally
• Must complete the NAAASP required qualification
• Currently Salford university course
• Due to change in April 2016
• Undertake accurate imaging and measuring of the aorta within NAAASP
• Ensure men attending are fully informed about the process and the potential
harms from screening
• Informed consent
• Provide results to patients (bad news and potential emergency referral)
• Update and understand SMaRT
• Must maintain their accreditation
• Programme and technician responsibility to ensure trained and accredited
8 London AAA update
9. Nurse specialist
• Counselling and providing healthcare advice to men who are
diagnosed as having an aneurysm via the screening programme
• Currently within 12 months
• Updated SOP’s to be released in next 6 months
• Within 12 weeks
• Face to face appointments
• Additional emphasis to be placed on this role over the next 18
months
• Potential to become involved with screening technician training
• Huge under utilised resource within the programme
9 London AAA update
10. Clinical skills trainer/QAlead (0.1&0.1 WTE)
• responsible for the clinical training and supervision of new and existing staff,
ensuring they are familiar with scanning techniques and the screening
programme procedures and high standards of work are maintained
• Senior sonographer or vascular scientist
• PgCert minimum/ SVT accreditation
• First line supervisor of the screening technicians
• Major role in e-learning package for new technicians
• On-going quality and quality assurance (QA lead)
• Reducing potential risk
• Regular feedback to techs
• Part of a National Screening Programme with National Protocols
• Small part of their role
• Large part of the screening programme
• Improved integration in last 12-18 months
10 London AAA update
11. Internal quality assurance requirements
• Robust internal QA framework has been in place since role-out
• Ensures that technicians are safe to work within programme
• Utilises SMaRT and documents online to aid programmes
• CST and co-ordinators must be aware of requirements for IQA
• Detailed during CST training
• All screening technicians and nurses undertaking screening must participate
in IQA
• Feedback needs to be given ideally by the CST
• Acceptable for the co-ordinator (currently)
11 London AAA update
12. Internal QAframework
• successful completion of the NAAASP approved training course for screening
technicians within 9 months from initial registration, a maximum of two
assessments is allowed
• a minimum of 200 scans per year, this must be spread over the 12 month period
and include at least one clinic session per month
• 24 of their scans reviewed by the local lead ultrasound clinician at least every six
months. This is the minimum requirement and more can be selected if required
• to have all abnormal scans reviewed by the QA lead/CST within 7 days
• each screener should have be clinically observed during one clinic by the CST at
least once every four months (a minimum of five subjects needs to be observed)
• undertake and successfully complete the NAAASP approved screening
technician re-accreditation every 24 months.
• It is the responsibility of the local screening programme to ensure that staff are
fully trained and accredited
12 London AAA update
13. Websites and communication
• Blog and emails
• Primary method of communication
• Helpdesk
• Send all queries
• Log queries
• Websites
• Gov.uk, NHS choices, CPD
• Extranet
13 London AAA update
14. • GOV.uk
• All professional related information
• Policy, procedures, standards
• All screening programmes and QA
• NHS choices
• All patient centred information
• Easy to read and understand
• accessible
• CPD website
• All education, training and eLearning
• Updates regarding the new qualification
• Generic eLearning modules/QA/induction
• Extranet
• Legacy site
• Has all old content, not updated
14 London AAA update
15. Screening Helpdesk phe.screeninghelpdesk@nhs.net
Professional information on gov.uk
https://www.gov.uk/topic/population-screening-programmes
Patient information on NHS Choices:
http://www.nhs.uk/conditions
CPD: http://cpd.screening.nhs.uk/
Blog: https://phescreening.blog.gov.uk/
Twitter: @PHE_Screening
Extranet archive:
http://abdominalaorticaneurysm.screening.nhs.uk
15 London AAA update
16. Documentation
• Quality assurance framework and resources for training in NAAASP
• http://cpd.screening.nhs.uk/cms.php?folder=5196
• Clinical guidance and scope of practice
• http://cpd.screening.nhs.uk/cms.php?folder=5196
• Clinical Skills Trainer Handbook
• http://cpd.screening.nhs.uk/cms.php?folder=5196
• Standard operating procedures
• https://www.gov.uk/government/publications/aaa-screening-standard-operating-procedures
• Scope of practice
• https://www.gov.uk/government/publications/aaa-screening-clinical-guidance-and-scope-of-
practice
• Pathway standards (quality standards)
• https://www.gov.uk/government/publications/aaa-screening-quality-standards-and-service-
objectives
• Screening technician handbook
• http://cpd.screening.nhs.uk/cms.php?folder=5195
• Gov.uk supporting docs
• https://www.gov.uk/government/collections/aaa-screening-supporting-documents
16 London AAA update
17. Education fromApril 2016
• PHE, HEE and Skills for Health are introducing an exciting new screener
qualification in 2016
• Clinical Healthcare Support Diploma in Healthcare (AAA Screening)
• Level 3 on QCF
• Provides the non-professionally regulated staff within screening a nationally
recognised qualification
• Will enable staff to have a huge number of opportunities and career
progression
• Other screening programmes
• Maternity support workers, healthcare support workers
• Nursing, paramedics, emergency medical technicians
• Foundation and undergraduate degrees
• Will be a big change to the existing qualification
17 London AAA update
18. Structure
• Core modules that cover competencies for underpinning of basic healthcare
• Communication skills
• Consent
• Infection control
• Health and safety in healthcare settings/safeguarding etc.
• Generic screening module
• To provide all staff in screening programmes a basic understanding of
screening and its importance in a healthcare setting
• Screening programme specific modules
• Different modules for different roles
• Screener, grader, admin etc.
• Certain staff groups will have exemption for prior learning
18 London AAA update
19. Assessment
• Change in structure to the current qualification
• Local assessors/internal and external quality assessors
• More local oversite
• CST’s/nurses/co-ordinators to become assessors to sign off techs
• Will take between 9-12 months to complete
• Clinical ‘sign off’ to enable semi independent scanning
• Work based assessment of competence
• Core modules competencies are demonstrated utilising their roles within their
departments
• Portfolio of experience (including minimum scans of AAA and non AAA)
• Clinical assessments
• E-learning
• On-line tests
• Assignments
• Case-studies/reflective practice
• Short notes
• Professional discussions
19 London AAA update
20. Assessors
• As this is a Nationally recognised qualification assessors of competence will
now need to have appropriate qualifications in vocational assessing
• Skills for health requirement
Clinical skills trainers
• CST’s still required for scanning assessment and will need to undertake this
qualification in vocational assessing
• Exemption for prior learning/block training of CST’s in new role
Accredited screening technicians
• Will allow role development for accredited screening technicians
• Can be officially involved in the training and assessing of new technicians
• Won’t be able to sign off clinical scanning competency (CST’s only)
• Will need to undertake the vocational assessors course locally
20 London AAA update
21. Costs
• Costs are determined by the individual awarding organisations
• Local centres will determine the costs based on the administration and
quality assurance requirements
• NAAASP can no longer subsidise the qualification
• £1000-2000/ registrant
• Funding may be available from the local education and training board within
Health Education England
• Local programmes need to contact wider workforce development team
within their LETB
• Dependent on local budgets and circumstances
• PHE are in discussion with senior management from HEE to obtain further
clarification regarding funding from a National perspective
21 London AAA update
22. Next steps
• NAAASP to;
• Produce website providing local programmes with updates
• Provide contact details of AO
• Facilitate programmes with administration process
• Produce new e-learning and assessment packages
• Produce full guidance and portfolio of experience for programmes
• Local programmes to;
• Contact and negotiate with LETB’s regarding funding
• Contact awarding organisations to determine locality of awarding centres
• Determine which AO is best suited to provide the qualification
• Register as awarding centre if required
• Liaise with awarding centre to determine process for registering learners
• Register internal assessors with awarding organisation
22 London AAA update